Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Neutropenia and GSTM1[original query] |
|---|
| Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms. Clinical pharmacology and therapeutics 2006 Jun 79 (6): 570-80. Tran A, Jullien V, Alexandre J, Rey E, Rabillon F, Girre V, Dieras V, Pons G, Goldwasser F, Tréluyer J |
| The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia. American journal of hematology 2007 Oct 82 (10): 906-10. Tumer Tugba Boyunegmez, Ulusoy Gulen, Adali Orhan, Sahin Gurses, Gozdasoglu Sevgi, Arinç Em |
| [Polymorphisms of RAD51(G135C) and XRCC3(C241T) genes and correlations thereof with prognosis and clinical outcomes of acute myeloid leukemia]. Zhonghua yi xue za zhi 2008 Feb 88 (6): 378-82. Liu Liang, Yang Lin, Zhang Yue, Xu Ze-Feng, Yu Ming-Hua, Wang Jian-Xiang, Xiao Zhi-Ji |
| Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. The pharmacogenomics journal 2010 Feb 10 (1): 54-61. Khrunin A V, Moisseev A, Gorbunova V, Limborska |
| Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients. Journal of human genetics 2009 Oct 54 (10): 564-71. Low Siew-Kee, Kiyotani Kazuma, Mushiroda Taisei, Daigo Yataro, Nakamura Yusuke, Zembutsu Hitos |
| Evaluating glutathione S-transferase (GST) null genotypes (GSTT1 and GSTM1) as a potential biomarker of predisposition for developing leukopenia. International journal of laboratory hematology 2010 Feb 32 (1 Pt 1): e49-56. Goncalves M S, Moura Neto J P, Souza C L, Melo P, Reis M |
| Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Jun 27 (17): 2863-73. Goekkurt Eray, Al-Batran Salah-Eddin, Hartmann Jörg T, Mogck Ulrike, Schuch Gunter, Kramer Michael, Jaeger Elke, Bokemeyer Carsten, Ehninger Gerhard, Stoehlmacher J |
| Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Jul 28 (20): 3227-33. McLeod Howard L, Sargent Daniel J, Marsh Sharon, Green Erin M, King Cristi R, Fuchs Charles S, Ramanathan Ramesh K, Williamson Stephen K, Findlay Brian P, Thibodeau Stephen N, Grothey Axel, Morton Roscoe F, Goldberg Richard |
| Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine. Cancer chemotherapy and pharmacology 2011 May . Joerger M, Burgers JA, Baas P, Doodeman VD, Smits PH, Jansen RS, Vainchtein LD, Rosing H, Huitema AD, Beijnen JH, Schellens JH |
| A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen. The pharmacogenomics journal 2013 Oct 13 (5): 403-9. Cecchin E, D'Andrea M, Lonardi S, Zanusso C, Pella N, Errante D, De Mattia E, Polesel J, Innocenti F, Toffoli |
| Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach. Molecular diagnosis & therapy 2013 Dec 17 (6): 371-9. Tulsyan Sonam, Chaturvedi Pankaj, Agarwal Gaurav, Lal Punita, Agrawal Sushma, Mittal Rama Devi, Mittal Balr |
| Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer. Cancer chemotherapy and pharmacology 2013 Jan . Lee KH, Chang HJ, Han SW, Oh DY, Im SA, Bang YJ, Kim SY, Lee KW, Kim JH, Hong YS, Kim TW, Park YS, Kang WK, Shin SJ, Ahn JB, Kang GH, Jeong SY, Park KJ, Park JG, Kim TY |
| Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. Scientific reports 2014 4 6828. Ruzzo Annamaria, Graziano Francesco, Galli Fabio, Giacomini Elisa, Floriani Irene, Galli Francesca, Rulli Eliana, Lonardi Sara, Ronzoni Monica, Massidda Bruno, Zagonel Vittorina, Pella Nicoletta, Mucciarini Claudia, Labianca Roberto, Ionta Maria Teresa, Veltri Enzo, Sozzi Pietro, Barni Sandro, Ricci Vincenzo, Foltran Luisa, Nicolini Mario, Biondi Edoardo, Bramati Annalisa, Turci Daniele, Lazzarelli Silvia, Verusio Claudio, Bergamo Francesca, Sobrero Alberto, Frontini Luciano, Magnani Mau |
| Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy. Cancer chemotherapy and pharmacology 2015 Apr 75 (4): 763-72. Joerger M, Huitema A D R, Boot H, Cats A, Doodeman V D, Smits P H M, Vainchtein L, Rosing H, Meijerman I, Zueger M, Meulendijks D, Cerny T D, Beijnen J H, Schellens J H |
| Can GSTM1 and GSTT1 polymorphisms predict clinical outcomes of chemotherapy in gastric and colorectal cancers? A result based on the previous reports. OncoTargets and therapy 2016 9 3683-94. Liu Haixia, Shi Wei, Zhao Lianli, Dai Dianlu, Gao Jinghua, Kong Xiangj |
| Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population. The pharmacogenomics journal 2016 May . van der Weide K, Loovers H, Pondman K, Bogers J, van der Straaten T, Langemeijer E, Cohen D, Commandeur J, van der Weide |
| Genetic Predictors of Azathioprine Toxicity and Clinical Response in Patients with Inflammatory Bowel Disease. Journal of population therapeutics and clinical pharmacology = Journal de la the?rapeutique des populations et de la pharamcologie clinique 2016 23 (1): e26-36. Al-Judaibi B, Schwarz U I, Huda N, Dresser G K, Gregor J C, Ponich T, Chande N, Mosli M, Kim R |
| Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy. BMC cancer 2017 Jul 17 (1): 502. Ludovini Vienna, Antognelli Cinzia, Rulli Antonio, Foglietta Jennifer, Pistola Lorenza, Eliana Rulli, Floriani Irene, Nocentini Giuseppe, Tofanetti Francesca Romana, Piattoni Simonetta, Minenza Elisa, Talesa Vincenzo Nicola, Sidoni Angelo, Tonato Maurizio, Crinò Lucio, Gori Stefan |
| Genetic Polymorphisms in Glutathione S-Transferase (GST) Gene and Their Correlation with Toxicity of Chemotherapy in Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2024 7 25 (7): 2271-2282. Rashmi A Gudur, Suresh J Bhosale, Anand K Gudur, Kailas D Datkhi |
- Page last reviewed:Feb 1, 2024
- Content source: